The interaction between Nrf2 and NF-κB has emerged as a significant target in kidney disease, since its modulation may reduce the pro-inflammatory cascade and boost the antioxidant response (Jaiswal 2004). The gene discussed is NFKB1; the disease is kidney disorder.